Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) and Shoulder Innovations (NYSE:SI – Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and earnings.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for Coloplast A/S and Shoulder Innovations, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Coloplast A/S | 1 | 1 | 0 | 2 | 2.75 |
| Shoulder Innovations | 1 | 0 | 5 | 0 | 2.67 |
Shoulder Innovations has a consensus price target of $25.75, suggesting a potential upside of 28.11%. Given Shoulder Innovations’ higher possible upside, analysts plainly believe Shoulder Innovations is more favorable than Coloplast A/S.
Valuation & Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Coloplast A/S | $4.50 billion | 3.61 | $478.04 million | $0.21 | 34.33 |
| Shoulder Innovations | $47.32 million | 8.89 | -$40.36 million | ($1.62) | -12.41 |
Coloplast A/S has higher revenue and earnings than Shoulder Innovations. Shoulder Innovations is trading at a lower price-to-earnings ratio than Coloplast A/S, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Coloplast A/S has a beta of 0.1, meaning that its stock price is 90% less volatile than the S&P 500. Comparatively, Shoulder Innovations has a beta of -1.51, meaning that its stock price is 251% less volatile than the S&P 500.
Profitability
This table compares Coloplast A/S and Shoulder Innovations’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Coloplast A/S | 10.57% | 42.25% | 11.87% |
| Shoulder Innovations | -51.72% | -25.37% | -20.87% |
Summary
Coloplast A/S beats Shoulder Innovations on 10 of the 13 factors compared between the two stocks.
About Coloplast A/S
Coloplast A/S is a Danish medical device company that develops and markets products and services for people with intimate health care needs. Its main business areas include ostomy care, continence care, wound and skin care, and urology care. Its products include ostomy bags and accessories, catheters and other continence products, wound dressings, and devices used in urological procedures. Coloplast also provides voice and respiratory care products, including solutions for people who have had a laryngectomy.
About Shoulder Innovations
Shoulder Innovations, Inc. is a medical technology company focused on developing and commercializing products for shoulder replacement surgery. Its offerings are designed for orthopedic surgeons treating patients with shoulder conditions that may require joint replacement. The company’s product portfolio includes shoulder implant systems such as its InSet glenoid and Catalyst reverse shoulder technologies, along with related surgical instruments. These products support different approaches to shoulder arthroplasty, including procedures that replace or reconstruct parts of the shoulder joint.
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
